Harbin Medisan Pharmaceutical Co Ltd (002900) — Cash Flow Quality Index
Harbin Medisan Pharmaceutical Co Ltd (002900) has a Cash Flow Quality Index of 1.32x as of September 2024. Operating cash flow of CN¥18.91 Million exceeds net income of CN¥14.31 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Harbin Medisan Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Harbin Medisan Pharmaceutical Co Ltd Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for Harbin Medisan Pharmaceutical Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 002900 cash flow metrics.
Annual Cash Flow Quality Index for Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Year-by-year earnings quality comparison for Harbin Medisan Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.56x | CN¥30.69 Million | CN¥54.98 Million | ▲ +15.2% |
| 2023 | 0.48x | CN¥35.69 Million | CN¥73.66 Million | ▼ -91.1% |
| 2022 | 5.46x | CN¥144.64 Million | CN¥26.50 Million | ▲ +15326.1% |
| 2021 | -0.04x | CN¥-12.53 Million | CN¥349.68 Million | ▲ +78.8% |
| 2020 | -0.17x | CN¥-4.51 Million | CN¥26.63 Million | ▼ -109.2% |
| 2019 | 1.84x | CN¥320.14 Million | CN¥173.86 Million | ▲ +28.7% |
| 2018 | 1.43x | CN¥292.46 Million | CN¥204.39 Million | ▲ +16.0% |
| 2017 | 1.23x | CN¥223.46 Million | CN¥181.08 Million | ▼ -6.5% |
| 2016 | 1.32x | CN¥231.18 Million | CN¥175.18 Million | ▲ +9.3% |
| 2015 | 1.21x | CN¥200.85 Million | CN¥166.30 Million | ▲ +52.6% |
| 2014 | 0.79x | CN¥116.31 Million | CN¥146.98 Million | ▼ -50.6% |
| 2013 | 1.60x | CN¥167.10 Million | CN¥104.39 Million | ▲ +7.5% |
| 2012 | 1.49x | CN¥123.22 Million | CN¥82.72 Million | — |